![]() |
|
|||||||
![]() |
|
|
أدوات الموضوع | انواع عرض الموضوع |
|
#1
|
|||
|
|||
|
NEW YORK (Reuters) - A U.S. regulatory probe of Valeant Pharmaceuticals International Inc , disclosed by the company on Monday, is focused on the drugmaker's relationship with specialty pharmacy Philidor RX Services and was triggered by Valeant’s own request that regulators investigate a short seller's allegations, people familiar with the matter said. ![]() ??????? ??????: Exclusive: SEC probe of Valeant began with review of short seller ? sources || ??????: ahlam1399 || ??????: اسم منتداك
|
![]() |
|
|